[Retracted] A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma

Figure 1

Online database analysis of the relationship between FKBP10 expression and the prognosis of patients with clear cell renal cell carcinoma. (a) HPA database displayed genes associated with renal cancer prognosis. The red bars represent oncogenes, and the green bars represent suppressor genes. (b) HPA database showed the top 20 genes associated with poor prognosis of renal cancer. (c) HPA database showed FKBP10 expression in clear cell renal cell carcinoma (CcRCC) tissues and normal tissues. (d) UALCAN database revealed the FKBP10 expression level in patients with different types of CcRCC, vs. normal, vs. male; & vs. Caucasian. (e) UALCAN database showed the relationship between FKBP10 expression and the survival analysis of patients with different types of CcRCC. (f) GEPIA database displayed FKBP10 expression in patients with CcRCC. Red indicates the CcRCC tumor group, and gray indicates the normal control group; vs. normal. (g) GEPIA database revealed the association between FKBP10 expression and the survival curve of patients with CcRCC.

(a)

(b)

(c)

(d)

(e)

(f)

(g)